AI assistant
Sending…
ARTIVION, INC. — Director's Dealing 2018
Sep 5, 2018
31684_dirs_2018-09-04_7bae335a-5fdc-48f2-9e10-339de5f6a2cb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CRYOLIFE INC (CRY)
CIK: 0000784199
Period of Report: 2018-08-30
Reporting Person: Capps Scott B (VP, Clinical Research)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-30 | Common Stock | M | 8332 | $5.67 | Acquired | 147419 | Direct |
| 2018-08-30 | Common Stock | S | 6332 | $34.1 | Disposed | 141087 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-30 | Stock Option (Right to Buy) | $5.67 | M | 8332 | Disposed | 2019-02-18 | Common Stock (8332) | Direct |
Footnotes
F1: Reflects weighted average price. Range was from $34.10 to $34.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F2: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/18/2013
More from ARTIVION, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3